Phase 1 dosing milestone for MEN2501 signals growing confidence in generative AI drug discovery and its healthspan implications.

vist.ly/4qmpn

#longevity #AIinBiotech #drugdiscovery #clinicalmilestone #healthspan #insilicomedicine